Works by Ferraris, Matias

Results: 12

Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.

Published in:

JAMA Neurology, 2024, v. 81, n. 5, p. 461, doi. 10.1001/jamaneurol.2024.0368

By:

Pozo-Rosich, Patricia;
Dolezil, David;
Paemeleire, Koen;
Stepien, Adam;
Stude, Philipp;
Snellman, Josefin;
Arkuszewski, Michal;
Stites, Tracy;
Ritter, Shannon;
Lopez Lopez, Cristina;
Maca, Jeff;
Ferraris, Matias;
Gil-Gouveia, Raquel

Publication type:

Article

Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain.

Published in:

Journal of Medical Economics, 2021, v. 24, p. 900, doi. 10.1080/13696998.2021.1953301

By:

Vo, Pamela;
Swallow, Elyse;
Wu, Eric;
Zichlin, Miriam L.;
Katcher, Noah;
Maier-Peuschel, Monika;
Naclerio, Mariantonietta;
Ritrovato, Daniela;
Tiwari, Santosh;
Joshi, Parth;
Ferraris, Matias

Publication type:

Article

Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain.

Published in:

Journal of Medical Economics, 2021, v. 24, n. 1, p. 900, doi. 10.1080/13696998.2021.1953301

By:

Vo, Pamela;
Swallow, Elyse;
Wu, Eric;
Zichlin, Miriam L.;
Katcher, Noah;
Maier-Peuschel, Monika;
Naclerio, Mariantonietta;
Ritrovato, Daniela;
Tiwari, Santosh;
Joshi, Parth;
Ferraris, Matias

Publication type:

Article

Management of Migraine and the Accessibility of Specialist Care: Findings from an Extended Multinational Survey (My Migraine Center Survey).

Published in:

Neurology & Therapy, 2020, v. 9, n. 2, p. 551, doi. 10.1007/s40120-020-00205-4

By:

Wongsiriroj, Siriporn;
Grillo, Elisabetta;
Levi, Sabrina;
Zielman, Ronald;
Lahouiri, Elia;
Marchina, Marco;
Pedrazzoli, Marco;
Ferraris, Matias

Publication type:

Article

Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey.

Published in:

Current Medical Research & Opinion, 2023, v. 39, n. 12, p. 1585, doi. 10.1080/03007995.2023.2191479

By:

Pathak, Purnima;
Yue, Leiyu;
Gupta, Shaloo;
Fang, Juanzhi;
Cheadle, M. Andy;
Tiwari, Santosh;
Ferraris, Matias;
Joshi, Parth;
Thompson, Jeffrey;
Shah, Roshani;
Vo, Pamela

Publication type:

Article

Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine.

Published in:

Current Medical Research & Opinion, 2023, v. 39, n. 1, p. 105, doi. 10.1080/03007995.2022.2131299

By:

Mahon, Ronan;
Vo, Pamela;
Pannagl, Katharina;
Tiwari, Santosh;
Heemstra, Harald;
Ferraris, Matias;
Zhao, Jing;
Betts, Keith A.;
Proot, Pascal

Publication type:

Article

Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study.

Published in:

Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01238-2

By:

Tepper, Stewart J.;
Fang, Juanzhi;
Vo, Pamela;
Shen, Ying;
Zhou, Lujia;
Abdrabboh, Ahmad;
Glassberg, Mrudula;
Ferraris, Matias

Publication type:

Article

Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study.

Published in:

Cephalalgia Reports, 2021, v. 4, p. 1, doi. 10.1177/25158163211040061

By:

Tepper, Stewart J;
Fang, Juanzhi;
Zhou, Lujia;
Vo, Pamela;
Abdrabboh, Ahmad;
Glassberg, Mrudula;
Ferraris, Matias

Publication type:

Article

Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States.

Published in:

Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1423, doi. 10.1111/head.14612

By:

Tepper, Stewart J.;
Schwedt, Todd J.;
Vo, Pamela;
Thompson, Jeffrey;
Joshi, Parth;
Abdrabboh, Ahmad;
Ferraris, Matias;
Tiwari, Santosh

Publication type:

Article

Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.

Published in:

2021

By:

Fang, Juanzhi;
Korrer, Stephanie;
Johnson, Jonathan C.;
Cheadle, Mark A.;
Shah, Roshani;
Ferraris, Matias L.;
Lopez-Lopez, Cristina

Publication type:

corrected article

Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.

Published in:

2021

By:

Fang, Juanzhi;
Korrer, Stephanie;
Johnson, Jonathan C.;
Cheadle, Mark A.;
Shah, Roshani;
Ferraris, Matias L.;
Lopez-Lopez, Cristina

Publication type:

corrected article

Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.

Published in:

2021

By:

Fang, Juanzhi;
Korrer, Stephanie;
Johnson, Jonathan C.;
Cheadle, Mark A.;
Shah, Roshani;
Ferraris, Matias L.;
Lopez-Lopez, Cristina;
Lopez, Cristina

Publication type:

journal article